Diabetes Mellitus and Covid-19: Modern Strategies
Downloads
The announcement of the COVID-19 pandemic in the world was followed by unprecedented measures to control the spread of the disease and find effective treatment and prevention regimens. The most vulnerable in these conditions were patients with diabetes mellitus.
In this article analyzes the literature data of recent years on the management, diagnosis, treatment and prevention of diabetes mellitus against the background of coronavirus infection.
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q. Prevalence of comorbidities and its effects in patients infected with SARS- CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95.
Yang L, Chan KP et al. Obesity and influenza associated mortality: evidence from an elderly cohort in Hong Kong. Prev Med. 2013;56(2):118–123.
Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, Gargiullo P et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A (N 1) disease. PLoS One. 2010;15;5(3):e9694.
Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell LF, Chernyak Y et al. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. Br Med J. 2020;369: m1966.
Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020. [Ahead of print, published online 9 April 2020].
Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infect Dis. 2020. [Ahead of print, published online 9 April 2020].
Xue T, Li Q, Zhang Q, Lin W, Wen J, Li L et al. Blood glucose levels in elderly subjects with type 2 diabetes during COVID-19 outbreak: a retrospective study in a single center. medRxiv. 2020. [Рublished online 2 April 2020].
Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE 2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586–590.
Turner AJ, Hooper NM. The angiotensin-converting enzyme gene family: genomics and pharmacology. Trends Pharmacol Sci. 2002;23(4):177–183.
Batlle D, Soler MJ, And Ye M. ACE 2 and Diabetes: ACE of ACEs? Diabetes. 2010;59(12):2994–2996. doi:10.2337/db10-1205
Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME. Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes. 2004;53(4):989–997.
Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol. 2006;17(11):3067– 3075.
Reich HN, Oudit GY, Penninger JM, Scholey JW, Herzenberg AM. Decreased glomerular and tubular expression of ACE 2 in patients with type 2 diabetes and kidney disease. Kidney Int. 2008;74(12):1610–1616.
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al. SARS-CoV-2 cell entry depends on ACE 2 and TMPRSS 2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.
Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single- cell RNA expression profiling of ACE 2, the putative receptor of Wuhan COVID-19. 2020.
Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J Virology. 2020;94(7):127–120.
Bornstein SR, Dalan R, Hopkins D, Mingrone G, Boehm BO. Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol. 2020;16(6):297–298.
Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382(17):1653–1659.
Yang JK, Lin SS. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47(3):193–199.
Carlsson PO, Berne C, Jansson L. Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia. 1998;41(2):127–133.
Roca-Ho H, Riera M, Palau V, Pascual J, Soler MJ. Characterization of ACE and ACE 2 expression within different organs of the NOD mouse. Int J Mol Sci. 2017;18(3):563.
Richard C, Wadowski M, Goruk S, Cameron L, Sharma AM, Field CJ. Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy. BMJ Open Diabetes Res Care. 2017;5(1): e000379.
Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97.
Ussher JR, Drucker DJ. Endocrine Reviews. 2012; 33(2):187–215.
Sell H, Blüher M, Klöting N, Schlich R, Willems M, Ruppe F et al. Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care. 2013;36(12):4083–4090.
Iacobellis G. COVID-19 and diabetes: Can DPP4 inhibition play a role? Diabetes Res Clin Pract. 2020;26(162):108–125.
Raj VS, Mou H, Smits SL, Dekkers DH, Müller MA, Dijkman R et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495(7440):251– 254.
Canton J, Fehr АR, Fernandez-Delgado R, Gutierrez- Alvarez FJ, Sanchez-Aparicio MT, García-Sastre A et al. MERS- CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection. PLoS Pathog. 2018;14(1):e1006838.
Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5(4):562–569.
Guo W, Li M et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020: e3319.
Guo J, Hang Z, Lin L, Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/ angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome Coronavirus 2 infection. J Am Heart Assoc. 2020;9(7): e016219.
Ma W-X, Ran X-W. The management of blood glucose should be emphasized in the treatment of COVID-19. Sichuan Da Xue Xue Bao Yi Xue Ban. 2020;51(2):146–150.
GrantWB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL at al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988.
Barnett JB, Hamer DH, Meydani SN. Low zinc status: a new risk factor for pneumonia in the elderly? Nutr Rev. 2010;68(1):30–37.
Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020;14(3):211–212.
Ma WX, Ran XW. The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19. Sichuan Da Xue Xue Bao Yi Xue Ban. 2020;51(2):146–150.
Amott C, Li Q, Kang A, Neuen BL, Bompoint S, Lam CSP et al. SGLT2i for the prevention of cardiovascular events in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. J Am Heart Assoc. 2020;9(3): e014198.
StrugaruAM, Botnariu G,Agoroaei L, Grigoriu IC, Butnaru E. Metformin induced lactic acidosis-particularities and course. Rev Med Chir Soc Med Nat Iasi. 2013;117(4):1035–1042.
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4): e21.
de Simone G. Position statement of the ESC Council on hypertension on ACE-inhibitors and angiotensin receptor blockers. [Electronic resource]. URL: https://www.escardio.org/Councils/
Yang W, Cai X, Han X, Ji L. DPP-4 inhibitors and risk of infections: a meta-analysis of randomized controlled trials. Diabetes Metab Res Rev. 2016;32(4):391–404.
Pasquel FJ, Fayfman M, Umpierrez GE. Debate on insulin vs non-insulin use in the hospital setting-is it time to revise the guidelines for the management of inpatient diabetes? Curr Diab Rep. 2019;19(9):65.
Botta L. Drug repurposing approaches to fight Dengue virus infection and related diseases. Front Biosci (Landmark Ed). 2018;23:997–1019.
All Content should be original and unpublished.
